Table of Contents
ISRN Oncology
Volume 2011 (2011), Article ID 403707, 7 pages
http://dx.doi.org/10.5402/2011/403707
Review Article

The Chemopreventive Properties and Therapeutic Modulation of Green Tea Polyphenols in Oral Squamous Cell Carcinoma

1Tooth Bioengineering National Research Lab, BK21, and Dental Research Institute, School of Dentistry, Seoul National University, Seoul 110-749, Republic of Korea
2Department of Oral & Maxillofacial Surgery, Hangang Sacred Heart Hospital, Hallym University, Seoul 140-719, Republic of Korea
3Oral Oncology Clinic, Research Institute and Hospital, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea

Received 25 February 2011; Accepted 20 March 2011

Academic Editor: A. Sapino

Copyright © 2011 Ui-Lyong Lee and Sung-Weon Choi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA: Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Google Scholar · View at Scopus
  2. M. E. Kupferman and J. N. Myers, “Molecular biology of oral cavity squamous cell carcinoma,” Otolaryngologic Clinics of North America, vol. 39, no. 2, pp. 229–247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. T. L. Vincent and R. A. Gatenby, “An evolutionary model for initiation, promotion and progression in carcinogenesis,” International Journal of Oncology, vol. 32, no. 4, pp. 729–737, 2008. View at Google Scholar · View at Scopus
  4. C. D. Fuller, S. J. Wang, C. R. Thomas Jr. et al., “Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973–1998,” Cancer, vol. 109, no. 7, pp. 1331–1343, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. E. Benner, T. F. Pajak, S. M. Lippman et al., “Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up,” Journal of the National Cancer Institute, vol. 86, no. 2, pp. 140–141, 1994. View at Google Scholar · View at Scopus
  6. W. K. Hong, S. M. Lippman, L. M. Itri et al., “Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck,” The New England Journal of Medicine, vol. 323, no. 12, pp. 795–801, 1990. View at Google Scholar · View at Scopus
  7. S. McDonald, C. Haie, P. Rubin et al., “Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment, and prevention,” International Journal of Radiation Oncology Biology Physics, vol. 17, no. 3, pp. 457–465, 1989. View at Google Scholar · View at Scopus
  8. Y. C. Ko, Y. L. Huang, C. H. Lee et al., “Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan,” Journal of Oral Pathology and Medicine, vol. 24, no. 10, pp. 450–453, 1995. View at Google Scholar · View at Scopus
  9. C. Fakhry and M. L. Gillison, “Clinical implications of human papillomavirus in head and neck cancers,” Journal of Clinical Oncology, vol. 24, no. 17, pp. 2606–2611, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Tran, B. R. Rose, and C. J. O'Brien, “Role of human papillomavirus in the etiology of head and neck cancer,” Head and Neck, vol. 29, no. 1, pp. 64–70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. B. Sporn, N. M. Dunlop, D. L. Newton, and J. M. Smith, “Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids),” Federation Proceedings, vol. 35, no. 6, pp. 1332–1338, 1976. View at Google Scholar · View at Scopus
  12. W. K. Hong, J. Endicott, L. M. Itri et al., “13-cis-retinoic acid in the treatment of oral leukoplakia,” The New England Journal of Medicine, vol. 315, no. 24, pp. 1501–1505, 1986. View at Google Scholar · View at Scopus
  13. S. Rajamanickam and R. Agarwal, “Natural products and colon cancer: current status and future prospects,” Drug Development Research, vol. 69, no. 7, pp. 460–471, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. Manson, P. B. Farmer, A. Gescher, and W. P. Steward, “Innovative agents in cancer prevention,” Recent Results in Cancer Research, vol. 166, pp. 257–275, 2005. View at Google Scholar · View at Scopus
  15. H. Nishino, Y. Satomi, H. Tokuda, and M. Masuda, “Cancer control by phytochemicals,” Current Pharmaceutical Design, vol. 13, no. 33, pp. 3394–3399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. C. Ho, S. F. Yang, C. Y. Peng et al., “Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator,” Journal of Oral Pathology and Medicine, vol. 36, no. 10, pp. 588–593, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. Q. Gu, C. Hu, Q. Chen et al., “Prevention of chinese green tea on 3,4-benzopyrene-induced lung cancer and its mechanism in animal mode,” Zhongguo Fei Ai Za Zhi, vol. 11, no. 4, pp. 519–523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. L. A. Beltz, D. K. Bayer, A. L. Moss, and I. M. Simet, “Mechanisms of cancer prevention by green and black tea polyphenols,” Anti-Cancer Agents in Medicinal Chemistry, vol. 6, no. 5, pp. 389–406, 2006. View at Google Scholar · View at Scopus
  19. D. A. Balentine, S. A. Wiseman, and L. C. Bouwens, “The chemistry of tea flavonoids,” Critical Reviews in Food Science and Nutrition, vol. 37, no. 8, pp. 693–704, 1997. View at Google Scholar · View at Scopus
  20. H. N. Graham, “Green tea composition, consumption, and polyphenol chemistry,” Preventive Medicine, vol. 21, no. 3, pp. 334–350, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Maron, G. P. Lu, N. S. Cai et al., “Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial,” Archives of Internal Medicine, vol. 163, no. 12, pp. 1448–1453, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Peters, C. Poole, and L. Arab, “Does tea affect cardiovascular disease? A meta-analysis,” American Journal of Epidemiology, vol. 154, no. 6, pp. 495–503, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. B. T. Ji, W. H. Chow, A. W. Hsing et al., “Green tea consumption and the risk of pancreatic and colorectal cancers,” International Journal of Cancer, vol. 70, no. 3, pp. 255–258, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. G. P. Yu, C. C. Hsieh, L. Y. Wang et al., “Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China,” Cancer Causes and Control, vol. 6, no. 6, pp. 532–538, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Imai, K. Suga, and K. Nakachi, “Cancer-preventive effects of drinking green tea among a Japanese population,” Preventive Medicine, vol. 26, no. 6, pp. 769–775, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. S. K. Myung, W. K. Bae, S. M. Oh et al., “Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies,” International Journal of Cancer, vol. 124, no. 3, pp. 670–677, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Seely, E. J. Mills, P. Wu et al., “The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis,” Integrative Cancer Therapies, vol. 4, no. 2, pp. 144–155, 2005. View at Publisher · View at Google Scholar
  28. S. K. Katiyar, F. Afaq, K. Azizuddin, and H. Mukhtar, “Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate,” Toxicology and Applied Pharmacology, vol. 176, no. 2, pp. 110–117, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. S. K. Katiyar and H. Mukhtar, “Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress,” Journal of Leukocyte Biology, vol. 69, no. 5, pp. 719–726, 2001. View at Google Scholar · View at Scopus
  30. J. Kim, J. S. Hwang, Y. K. Cho et al., “Protective effects of (-)-epigallocatechin-3-gallate on UVA- and UVB-induced skin damage,” Skin Pharmacology and Applied Skin Physiology, vol. 14, no. 1, pp. 11–19, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. I. R. Record and I. E. Dreosti, “Protection by black tea and green tea against UVB and UVA+B induced skin cancer in hairless mice,” Mutation Research, vol. 422, no. 1, pp. 191–199, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Mukhtar and N. Ahmad, “Tea polyphenols: prevention of cancer and optimizing health,” American Journal of Clinical Nutrition, vol. 71, supplement 6, pp. 1698S–1702S, 2000. View at Google Scholar
  33. E. Middleton Jr., C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000. View at Google Scholar · View at Scopus
  34. B. T. Wu, P. F. Hung, H. C. Chen et al., “The apoptotic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the Cdk2 pathway,” Journal of Agricultural and Food Chemistry, vol. 53, no. 14, pp. 5695–5701, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Ahmad and H. Mukhtar, “Green tea polyphenols and cancer: biologic mechanisms and practical implications,” Nutrition Reviews, vol. 57, no. 3, pp. 78–83, 1999. View at Google Scholar · View at Scopus
  36. J. Jankun, S. H. Selman, R. Swiercz, and E. Skrzypczak-Jankun, “Why drinking green tea could prevent cancer,” Nature, vol. 387, no. 6633, p. 561, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. L. J. Su and L. Arab, “Tea consumption and the reduced risk of colon cancer—results from a national prospective cohort study,” Public Health Nutrition, vol. 5, no. 3, pp. 419–425, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. C. S. Yang, “Inhibition of carcinogenesis and toxicity by dietary constituents,” Advances in Experimental Medicine and Biology, vol. 500, pp. 541–550, 2001. View at Google Scholar · View at Scopus
  39. M. Zhang, A. H. Lee, C. W. Binns, and X. Xie, “Green tea consumption enhances survival of epithelial ovarian cancer,” International Journal of Cancer, vol. 112, no. 3, pp. 465–469, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. V. M. Adhami, N. Ahmad, and H. Mukhtar, “Molecular targets for green tea in prostate cancer prevention,” Journal of Nutrition, vol. 133, no. 7, pp. 2417S–2424S, 2003. View at Google Scholar · View at Scopus
  41. S. D. Hsu, B. B. Singh, J. B. Lewis et al., “Chemoprevention of oral cancer by green tea,” General Dentistry, vol. 50, no. 2, pp. 140–146, 2002. View at Google Scholar · View at Scopus
  42. J. Ju, J. Hong, J. N. Zhou et al., “Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea,” Cancer Research, vol. 65, no. 22, pp. 10623–10631, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. J. D. Lambert, J. Hong, G. Y. Yang et al., “Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations,” The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 284S–291S, 2005. View at Google Scholar · View at Scopus
  44. M. Masuda, M. Suzui, J. T. Lim et al., “Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction,” Journal of Experimental Therapeutics and Oncology, vol. 2, no. 6, pp. 350–359, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Masuda, M. Suzui, J. T. Lim, and I. B. Weinstein, “Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells,” Clinical Cancer Research, vol. 9, no. 9, pp. 3486–3491, 2003. View at Google Scholar · View at Scopus
  46. C. S. Yang, P. Maliakal, and X. Meng, “Inhibition of carcinogenesis by tea,” Annual Review of Pharmacology and Toxicology, vol. 42, pp. 25–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Demeule, J. Michaud-Levesque, B. Annabi et al., “Green tea catechins as novel antitumor and antiangiogenic compounds,” Current Medicinal Chemistry—Anti-Cancer Agents, vol. 2, no. 4, pp. 441–463, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. T. K. Maiti, J. Chatterjee, and S. Dasgupta, “Effect of green tea polyphenols on angiogenesis induced by an angiogenin-like protein,” Biochemical and Biophysical Research Communications, vol. 308, no. 1, pp. 64–67, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Masuda, M. Suzui, and I. B. Weinstein, “Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines,” Clinical Cancer Research, vol. 7, no. 12, pp. 4220–4229, 2001. View at Google Scholar · View at Scopus
  50. I. Naasani, H. Seimiya, and T. Tsuruo, “Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins,” Biochemical and Biophysical Research Communications, vol. 249, no. 2, pp. 391–396, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Boehm, F. Borrelli, E. Ernst et al., “Green tea (Camellia sinensis) for the prevention of cancer,” Cochrane Database of Systematic Reviews, vol. 8, no. 3, Article ID CD005004, 2009. View at Google Scholar · View at Scopus
  52. J. H. Weisburg, D. B. Weissman, T. Sedaghat, and H. Babich, “In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity,” Basic and Clinical Pharmacology and Toxicology, vol. 95, no. 4, pp. 191–200, 2004. View at Google Scholar · View at Scopus
  53. H. Babich, M. E. Krupka, H. A. Nissim, and H. L. Zuckerbraun, “Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity,” Toxicology in Vitro, vol. 19, no. 2, pp. 231–242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Khafif, S. P. Schantz, M. Al-Rawi et al., “Green tea regulates cell cycle progression in oral leukoplakia,” Head and Neck, vol. 20, no. 6, pp. 528–534, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. X. Liu, D. Y. Zhang, W. Zhang et al., “The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma,” Nutrition and Cancer, vol. 63, no. 3, pp. 466–475, 2011. View at Google Scholar
  56. S. Hsu, J. Lewis, B. Singh et al., “Green tea polyphenol targets the mitochondria in tumor cells inducing caspase 3-dependent apoptosis,” Anticancer Research, vol. 23, no. 2, pp. 1533–1539, 2003. View at Google Scholar · View at Scopus
  57. S. Hsu, K. Farrey, J. Wataha et al., “Role of p21WAF1 in green tea polyphenol-induced growth arrest and apoptosis of oral carcinoma cells,” Anticancer Research, vol. 25, no. 1, pp. 63–67, 2005. View at Google Scholar · View at Scopus
  58. W. Xia, Y. K. Lau, H. Z. Zhang et al., “Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members,” Clinical Cancer Research, vol. 5, no. 12, pp. 4164–4174, 1999. View at Google Scholar · View at Scopus
  59. D. Yu and M. C. Hung, “Overexpression of ErbB2 in cancer and ErbB2-targeting strategies,” Oncogene, vol. 19, no. 53, pp. 6115–6121, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. H. C. Chang, C. Y. Cho, and W. C. Hung, “Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation,” Cancer Research, vol. 66, no. 17, pp. 8413–8420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. H. C. Chang, C. Y. Cho, and W. C. Hung, “Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer,” Cancer Science, vol. 98, no. 2, pp. 169–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Y. Cho, J. H. Wang, H. C. Chang et al., “Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells,” Journal of Cellular Physiology, vol. 213, no. 1, pp. 65–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. P. N. Chen, S. C. Chu, W. H. Kuo et al., “Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells,” Journal of Agricultural and Food Chemistry, vol. 59, no. 8, pp. 3836–3844, 2011. View at Google Scholar
  64. N. K. Long, K. Kato, T. Yamashita et al., “Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas,” Oral Oncology, vol. 44, no. 11, pp. 1052–1058, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Kato, N. K. Long, H. Makita et al., “Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells,” British Journal of Cancer, vol. 99, no. 4, pp. 647–654, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. G. Shklar, J. Schwartz, D. Trickler, and S. Reid, “Regression of experimental cancer by oral administration of combined alpha-tocopherol and beta-carotene,” Nutrition and Cancer, vol. 12, no. 4, pp. 321–325, 1989. View at Google Scholar · View at Scopus
  67. J. L. Schwartz, J. Tanaka, V. Khandekar et al., “Beta-carotene and/or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells,” Cancer Chemotherapy and Pharmacology, vol. 29, no. 3, pp. 207–213, 1992. View at Google Scholar · View at Scopus
  68. A. Khafif, S. P. Schantz, T. C. Chou et al., “Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells,” Carcinogenesis, vol. 19, no. 3, pp. 419–424, 1998. View at Publisher · View at Google Scholar · View at Scopus
  69. K. V. Mohan, P. Gunasekaran, E. Varalakshmi et al., “In vitro evaluation of the anticancer effect of lactoferrin and tea polyphenol combination on oral carcinoma cells,” Cell Biology International, vol. 31, no. 6, pp. 599–608, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. A. R. Amin, F. R. Khuri, Z. G. Chen, and D. M. Shin, “Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB,” Cancer Prevention Research, vol. 2, no. 6, pp. 538–545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. T. Yamamoto, J. Staples, J. Wataha et al., “Protective effects of EGCG on salivary gland cells treated with gamma-radiation or cis-platinum(II)diammine dichloride,” Anticancer Research, vol. 24, no. 5, pp. 3065–3073, 2004. View at Google Scholar · View at Scopus
  72. S. R. Moore, N. W. Johnson, A. M. Pierce, and D. F. Wilson, “The epidemiology of mouth cancer: a review of global incidence,” Oral Diseases, vol. 6, no. 2, pp. 65–74, 2000. View at Google Scholar · View at Scopus
  73. K. V. Chandra Mohan, Y. Hara, S. K. Abraham, and S. Nagini, “Comparative evaluation of the chemopreventive efficacy of green and black tea polyphenols in the hamster buccal pouch carcinogenesis model,” Clinical Biochemistry, vol. 38, no. 10, pp. 879–886, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. N. Li, C. Han, and J. Chen, “Tea preparations protect against DMBA-induced oral carcinogenesis in hamsters,” Nutrition and Cancer, vol. 35, no. 1, pp. 73–79, 1999. View at Google Scholar · View at Scopus
  75. T. Sugimura, “Multistep carcinogenesis: a 1992 perspective,” Science, vol. 258, no. 5082, pp. 603–607, 1992. View at Google Scholar · View at Scopus
  76. P. Srinivasan, S. Suchalatha, P. V. Babu et al., “Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer,” Chemico-Biological Interactions, vol. 172, no. 3, pp. 224–234, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. D. E. Hansel, A. Rahman, S. Wehner et al., “Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation,” Cancer Research, vol. 63, no. 21, pp. 7032–7037, 2003. View at Google Scholar · View at Scopus
  78. J. Y. Meng, H. Kataoka, H. Itoh, and M. Koono, “Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo,” International Journal of Cancer, vol. 92, no. 1, pp. 31–39, 2001. View at Google Scholar · View at Scopus
  79. S. Y. Ko, K. W. Chang, S. C. Lin et al., “The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo,” Cancer Letters, vol. 245, no. 1-2, pp. 81–89, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. J. L. Schwartz, V. Baker, E. Larios, and F. L. Chung, “Molecular and cellular effects of green tea on oral cells of smokers: a pilot study,” Molecular Nutrition and Food Research, vol. 49, no. 1, pp. 43–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. N. Li, Z. Sun, C. Han, and J. Chen, “The chemopreventive effects of tea on human oral precancerous mucosa lesions,” Proceedings of the Society for Experimental Biology and Medicine, vol. 220, no. 4, pp. 218–224, 1999. View at Google Scholar · View at Scopus
  82. A. S. Tsao, D. Liu, J. Martin et al., “Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions,” Cancer Prevention Research, vol. 2, no. 11, pp. 931–941, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Ide, Y. Fujino, Y. Hoshiyama et al., “A prospective study of green tea consumption and oral cancer incidence in Japan,” Annals of Epidemiology, vol. 17, no. 10, pp. 821–826, 2007. View at Publisher · View at Google Scholar · View at Scopus